We obtained the expression matrix of SUSD4 in various cancer cell lines through the CCLE database and found that the expression level of SUSD4 was highest in breast cancer, while it was lowest in lymphoma, rhabdoid, and myeloma (Figure 1C). This evidence concerns the gene SUSD4 and plasma cell myeloma.